{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:44:51Z","timestamp":1775303091031,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.07.087","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T09:14:41Z","timestamp":1281690881000},"page":"7109-7116","source":"Crossref","is-referenced-by-count":19,"title":["Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination"],"prefix":"10.1016","volume":"28","author":[{"given":"Simon O.","family":"Clark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic L.F.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Badell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Roberto","family":"Castello-Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Aldwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.07.087_bib0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2796.2007.01795.x","article-title":"The TB pandemic: an old problem seeking new solutions","volume":"261","author":"Meya","year":"2007","journal-title":"J Intern Med"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.07.087_bib0010","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1471-4906(01)01865-8","article-title":"TB vaccines: progress and problems","volume":"22","author":"Andersen","year":"2001","journal-title":"Trends Immunol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2010.07.087_bib0015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1711.2005.01369.x","article-title":"Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: anatomical sites of bacterial replication and immune activity","volume":"83","author":"Aldwell","year":"2005","journal-title":"Immunol Cell Biol"},{"issue":"March (9)","key":"10.1016\/j.vaccine.2010.07.087_bib0020","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.07.087_bib0025","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/IAI.73.4.2190-2196.2005","article-title":"Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens","volume":"73","author":"Demangel","year":"2005","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.07.087_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG\u2014different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2010.07.087_bib0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0197-2456(94)90042-6","article-title":"Field trials of tuberculosis vaccines: how could we have done them better?","volume":"15","author":"Comstock","year":"1994","journal-title":"Control Clin Trials"},{"issue":"November (8986)","key":"10.1016\/j.vaccine.2010.07.087_bib0040","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2010.07.087_bib0045","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/14760584.7.5.635","article-title":"Tuberculosis: vaccines in the pipeline","volume":"7","author":"Ly","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2010.07.087_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vaccine.2008.10.034","article-title":"Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells","volume":"27","author":"Badell","year":"2009","journal-title":"Vaccine"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2010.07.087_bib0055","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1586\/14760584.7.8.1257","article-title":"Mucosal vaccination against bacterial respiratory infections","volume":"7","author":"Baumann","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"November\u2013December (14\u201315)","key":"10.1016\/j.vaccine.2010.07.087_bib0060","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.micinf.2008.09.004","article-title":"Immunogenicity of orally-delivered lipid-formulated BCG vaccines and protection against Mycobacterium tuberculosis infection","volume":"10","author":"Vipond","year":"2008","journal-title":"Microbes Infect"},{"issue":"January\u2013March (1\u20132)","key":"10.1016\/j.vaccine.2010.07.087_bib0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"issue":"August (5)","key":"10.1016\/j.vaccine.2010.07.087_bib0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1590\/S0074-02762005000500002","article-title":"BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis\u2014review","volume":"100","author":"Benevolo-de-Andrade","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.07.087_bib0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/IAI.71.1.101-108.2003","article-title":"Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice","volume":"71","author":"Aldwell","year":"2003","journal-title":"Infect Immun"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2010.07.087_bib0080","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7589\/0090-3558-45.3.754","article-title":"Lipid-formulated BCG as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy, and palatability to brushtail possums (Trichosurus vulpecula) in New Zealand","volume":"45","author":"Cross","year":"2009","journal-title":"J Wildl Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.07.087_bib0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0092-1157(88)90025-X","article-title":"The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine","volume":"16","author":"Gheorghiu","year":"1988","journal-title":"J Biol Stand"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.07.087_bib0090","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1128\/CVI.00198-09","article-title":"An oral Mycobacterium bovis BCG vaccine for wildlife produced in the absence of animal-derived reagents","volume":"16","author":"Cross","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"June (Suppl.) (3)","key":"10.1016\/j.vaccine.2010.07.087_bib0095","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1086\/313878","article-title":"Comparison of the protective efficacy of bacille Calmette\u2013Guerin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis","volume":"30","author":"Williams","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.07.087_bib0100","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1128\/IAI.68.12.7094-7099.2000","article-title":"Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin","volume":"68","author":"Chambers","year":"2000","journal-title":"Infect Immun"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.07.087_bib0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2672.2000.00807.x","article-title":"Survival of mycobacterial species in aerosols generated from artificial saliva","volume":"31","author":"Lever","year":"2000","journal-title":"Lett Appl Microbiol"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2010.07.087_bib0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0378-1135(00)00378-3","article-title":"A guinea pig model of low-dose Mycobacterium bovis aerogenic infection","volume":"80","author":"Chambers","year":"2001","journal-title":"Vet Microbiol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.07.087_bib0115","first-page":"422","article-title":"Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs","volume":"102","author":"Wiegeshaus","year":"1970","journal-title":"Am Rev Respir Dis"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2010.07.087_bib0120","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tube.2004.11.001","article-title":"An assay to compare the infectivity of Mycobacterium tuberculosis isolates based on aerosol infection of guinea pigs and assessment of bacteriology","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"issue":"August 8","key":"10.1016\/j.vaccine.2010.07.087_bib0125","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1586\/erv.09.61","article-title":"Mucosal vaccines: novel advances in technology and delivery","volume":"8","author":"Yuki","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.07.087_bib0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect Immun"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2010.07.087_bib0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jinf.2005.12.017","article-title":"Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice","volume":"53","author":"Giri","year":"2006","journal-title":"J Infect"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.07.087_bib0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4161\/hv.5.2.7210","article-title":"BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy","volume":"5","author":"Liu","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2010.07.087_bib0145","first-page":"107","article-title":"BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics","volume":"21","author":"Lotte","year":"1984","journal-title":"Adv Tuberc Res"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.07.087_bib0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1054\/tube.2000.0253","article-title":"Comparative genomics of BCG vaccines","volume":"81","author":"Behr","year":"2001","journal-title":"Tuberculosis (Edinb)"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2010.07.087_bib0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1574-695X.2009.00559.x","article-title":"Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette\u2013Guerin (BCG) substrains","volume":"56","author":"Hayashi","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2010.07.087_bib0160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.vaccine.2008.10.058","article-title":"Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis","volume":"27","author":"Horwitz","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.07.087_bib0165","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2010.07.087_bib0170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tube.2009.08.004","article-title":"Evaluation of new vaccines for tuberculosis in the guinea pig model","volume":"89","author":"Williams","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"issue":"September\u2013October (7\u20138)","key":"10.1016\/j.vaccine.2010.07.087_bib0175","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0923-2508(90)90132-A","article-title":"Recombinant BCG as a candidate oral vaccine vector","volume":"141","author":"Barletta","year":"1990","journal-title":"Res Microbiol"},{"issue":"47","key":"10.1016\/j.vaccine.2010.07.087_bib0180","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1016\/j.vaccine.2009.08.044","article-title":"Recombinant Mycobacterium bovis BCG","volume":"27","author":"Bastos","year":"2009","journal-title":"Vaccine"},{"issue":"August (6\u20137)","key":"10.1016\/j.vaccine.2010.07.087_bib0185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1865-1682.2008.01058.x","article-title":"Evaluation of granulysin and perforin as candidate biomarkers for protection following vaccination with Mycobacterium bovis BCG or M. bovisDeltaRD1","volume":"56","author":"Capinos Scherer","year":"2009","journal-title":"Transbound Emerg Dis"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2010.07.087_bib0190","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1128\/JVI.02544-08","article-title":"Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses","volume":"83","author":"Cayabyab","year":"2009","journal-title":"J Virol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.07.087_bib0195","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette\u2013Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"issue":"December (25)","key":"10.1016\/j.vaccine.2010.07.087_bib0200","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus calmette\u2013guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.07.087_bib0205","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"issue":"September (Suppl.) (3)","key":"10.1016\/j.vaccine.2010.07.087_bib0210","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette\u2013Guerin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T21:58:30Z","timestamp":1544306310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10011102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":42,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0264410X10011102"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}